Brainstorm Cell Therapeutics Inc. financial data

Symbol
BCLI on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
1325 Avenue Of Americas, 28 Th Floor, New York, New York
State of incorporation
Delaware
Fiscal year end
December 31
Former names
GOLDEN HAND RESOURCES INC (to 11/22/2004), WIZBANG TECHNOLOGIES INC (to 8/8/2003)
Latest financial report
Q1 2024 - May 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 20.6 % -71.8%
Debt-to-equity -213 % -106%
Return On Equity 368 %
Return On Assets -327 % -65.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 68.3 M shares +86.3%
Common Stock, Shares, Outstanding 68.4 M shares +77.9%
Entity Public Float 78.9 M USD -34%
Common Stock, Value, Issued 13 K USD +8.33%
Weighted Average Number of Shares Outstanding, Basic 64.7 M shares +76.2%
Weighted Average Number of Shares Outstanding, Diluted 64.7 M shares +76.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 8.78 M USD -38.4%
General and Administrative Expense 9.98 M USD -2.49%
Operating Income (Loss) -18.8 M USD +23.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -17.2 M USD +29.2%
Net Income (Loss) Attributable to Parent -15.5 M USD +35.2%
Earnings Per Share, Basic -0.31 USD/shares +52.3%
Earnings Per Share, Diluted -0.31 USD/shares +52.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 779 K USD -61.5%
Assets, Current 1.26 M USD -57%
Property, Plant and Equipment, Net 622 K USD -28.2%
Operating Lease, Right-of-Use Asset 1.27 M USD -68.8%
Other Assets, Noncurrent 2.09 M USD -57.7%
Assets 3.35 M USD -57.5%
Accounts Payable, Current 4.69 M USD -39.9%
Employee-related Liabilities, Current 917 K USD
Accrued Liabilities, Current 636 K USD +272%
Liabilities, Current 6.83 M USD -34.5%
Operating Lease, Liability, Noncurrent 533 K USD -76.7%
Liabilities 8.9 M USD -30%
Retained Earnings (Accumulated Deficit) -218 M USD -7.66%
Stockholders' Equity Attributable to Parent -5.55 M USD -14.7%
Liabilities and Equity 3.35 M USD -57.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.5 M USD +0.42%
Net Cash Provided by (Used in) Financing Activities 18.3 M USD -21.4%
Net Cash Provided by (Used in) Investing Activities 2.19 M USD +120%
Common Stock, Shares Authorized 100 M shares 0%
Common Stock, Shares, Issued 68.4 M shares +77.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -1.06 M USD +91.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 961 K USD -52.4%
Deferred Tax Assets, Valuation Allowance 50.8 M USD +19%
Deferred Tax Assets, Gross 50.8 M USD +19%
Operating Lease, Liability 1.12 M USD -69.5%
Depreciation 262 K USD -5.76%
Payments to Acquire Property, Plant, and Equipment 18 K USD -37.9%
Lessee, Operating Lease, Liability, to be Paid 1.21 M USD -69.8%
Property, Plant and Equipment, Gross 3.45 M USD +0.53%
Operating Lease, Liability, Current 588 K USD -57.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 186 K USD -86.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 568 K USD -46.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure +29.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 85 K USD -72.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 189 K USD -86%
Lessee, Operating Lease, Liability, to be Paid, Year Four 179 K USD -7.25%
Operating Lease, Payments 166 K USD -57%